( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
164410
162410
165140
156700
Total Expenditure
126530
125120
127960
120510
PBIDT (Excl OI)
37880
37290
37180
36190
Other Income
1390
1470
2010
3090
Operating Profit
39270
38760
39190
39280
Exceptional Items
-5760
1840
-1270
-1380
Depreciation
3370
3580
3610
3470
Profit Before Tax
29260
35730
33040
33630
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
21250
26970
27690
24760
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
66100
26970
27690
24760
Minority Interest
40
-90
-120
-110
Shares of Associates
-70
-30
-10
-10
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
66070
26850
27560
24640
Equity Capital
2350
2350
2350
2350
Calculated EPS
28.11
11.42
11.72
10.48
Calculated EPS (Annualised)
112.45
45.70
46.91
41.94
No of Public Share Holdings
895178404
895178404
895178404
895178404
% of Public Share Holdings
38.1
38.1
38.1
38.1
PBIDTM% (Excl OI)
23.03
22.96
22.51
23.09
PBIDTM%
23.88
23.86
23.73
25.06
PBDTM%
19.84
24.20
22.19
23.67
PBTM%
17.79
21.99
20.00
21.46
PATM%
12.92
16.60
16.76
15.80